Vancouver, British Columbia – (Accesswire) – Monday October 21, 2019 – Stillcanna Inc. (OTC:SCNNF) (CSE:STIL) (FRANKFURT:A2PEWA) (“STIL” or the “Enterprise”) is pleased to announce that it has hired two more group members for the Company’s NEXUS extraction facility in Poland. Mr. Kazimierz Malik as Basic Manager and Mr. Piotr Bawiec, as Excellent Assurance Manager.
Mr. Malik, now Basic Manager of the extraction facility, brings more than 30 years of organization administration expertise, like the management of a network of health-related clinics. Mr. Malik, a former professor at the University of Zielona Gora in Poland holds a Master’s Degree in philosophy and sociology. From each day logistical arranging and oversight to production implementation and Normal Operating Procedures (SOP) s’, Mr. Malik will be accountable for the day-to-day operations of the NEXUS facility.
Mr. Piotr Bawiec has his pharmaceutical Masters Degree and is finishing his doctorate in particular molecule evaluation. He is a published researcher in Pharmacy and Healthcare Sciences dealing with particular trace molecules in many meals goods. Mr. Bawiec, the Excellent Assurance Manager of the NEXUS facility will be focused on high quality manage and solution testing all through the extraction approach.
Kazimierz Malik, Basic Manager and Piotr Bawiec, Excellent Assurance Manager
“We continue to attract robust group members for Stillcanna and our Polish operations,” pointed out Jason Dussault CEO of Stillcanna. “You cannot anticipate to realize good factors devoid of good men and women, I really feel we just recruited however an additional two. We welcome Piotr and Kazimierz to the Stillcanna household and we appear forward to their contributions in meeting our milestones each right now and in the future.”
About Stillcanna Inc.
Stillcanna Inc. (CSE: STIL) www.stillcanna.com is a Canadian early-stage life sciences enterprise focused on the huge scale manufacturing of CBD in Europe. The Enterprise believes its proprietary intellectual home makes it possible for it to extract CBD at a reduced price. The Enterprise has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences LLC, a United Kingdom-primarily based supplier of CBD. The Enterprise also lately completed the acquisition of Olimax NT SP. Z .O.O, a multi-generational hemp agricultural firm that is anticipated to enhance the Company’s market place share in the European CBD sector.
On Behalf of the Board
Jason Dussault, CEO
Make contact with: